Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: NeuroRehabilitation. 2011;28(2):151–160. doi: 10.3233/NRE-2011-0643

Table 4.

Combined Treatments

Study Characteristics: Author/Yr N Design-Quality Score Population Treatment
Treatment Dosage/Frequency Time post Injury
Kolessar et al. 1996
N=17
Case series-D&B=15
BI Excision/Indomethacin/Etidronate Indomethacin (75 mg/day) + Etidronate (20 mg/kg/day) Mean of 30 months
Fuller et al. 2005
N=17
Case series-D&B=14
BI Excision/Etidronate 20 mg/kg body weight for 2 months Not stated
Lazarus et al. 1999
N=24
Pre-Post-D&B=13
BI Excision/Indomethacin Indomethacin 25–50mg Average of 35.4 months
Ippolito et al. 1999a
N=12
Pre-Post-D&B=12
BI Excision N/A Not stated
Moore 1993
N=17
Case series-D&B=9
BI Excision/Etidronate 10mg/kg body weight per day for 3 months Not stated
Schuetz et al. 2005
N=5
Case studies-D&B=9
SCI Excision/Pamidronate 120 mg for 12 hrs post surgery and then increase over 6–14 days. Not stated
Subbarao et al. 1987
N=5
Case series-D&B=8
SCI Excision/Etidronate 20 mg/kg body weight preoperatively for 10–14 days
10 mg/kg body weight post-operatively for at least 3 months
Not stated
Kolessar et al. 1996
N=17
Case series-D&B=15
BI Excision/Indomethacin/Etidronate Indomethacin (75 mg/day) + Etidronate (20 mg/kg/day) Mean of 30 months
Charnley et al. 1996
N=5
Case series-D&B=9
BI Excision/Indomethacin Not stated Over 18 months
De Palma et al. 2002
N=10
Case series-D&B=8
BI Excision/Indomethacin/active motion therapy 25 mg 3 times a day for 6 weeks 18–20 months